These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 34819011)

  • 1. Applications of Genome Editing Tools in Stem Cells Towards Regenerative Medicine: An Update.
    Kues WA; Kumar D; Selokar NL; Talluri TR
    Curr Stem Cell Res Ther; 2022; 17(3):267-279. PubMed ID: 34819011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9: an advanced tool for editing plant genomes.
    Samanta MK; Dey A; Gayen S
    Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
    Eid A; Mahfouz MM
    Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
    Vermersch E; Jouve C; Hulot JS
    Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene editing and CRISPR in the clinic: current and future perspectives.
    Hirakawa MP; Krishnakumar R; Timlin JA; Carney JP; Butler KS
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32207531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basics of genome editing technology and its application in livestock species.
    Petersen B
    Reprod Domest Anim; 2017 Aug; 52 Suppl 3():4-13. PubMed ID: 28815851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining Induced Pluripotent Stem Cells and Genome Editing Technologies for Clinical Applications.
    Chang CY; Ting HC; Su HL; Jeng JR
    Cell Transplant; 2018 Mar; 27(3):379-392. PubMed ID: 29806481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering of Zinc Finger Nucleases Through Structural Modeling Improves Genome Editing Efficiency in Cells.
    Katayama S; Watanabe M; Kato Y; Nomura W; Yamamoto T
    Adv Sci (Weinh); 2024 Jun; 11(23):e2310255. PubMed ID: 38600709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome Editing in Stem Cells for Disease Therapeutics.
    Song M; Ramakrishna S
    Mol Biotechnol; 2018 Apr; 60(4):329-338. PubMed ID: 29516417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome centric engineering using ZFNs, TALENs and CRISPR-Cas9 systems for trait improvement and disease control in Animals.
    Wani AK; Akhtar N; Singh R; Prakash A; Raza SHA; Cavalu S; Chopra C; Madkour M; Elolimy A; Hashem NM
    Vet Res Commun; 2023 Jan; 47(1):1-16. PubMed ID: 35781172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome editing in plants: Advancing crop transformation and overview of tools.
    Shah T; Andleeb T; Lateef S; Noor MA
    Plant Physiol Biochem; 2018 Oct; 131():12-21. PubMed ID: 29754773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and Evaluation of Zinc Finger Nucleases.
    Ochiai H; Yamamoto T
    Methods Mol Biol; 2023; 2637():1-25. PubMed ID: 36773134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A beginner's guide to gene editing.
    Harrison PT; Hart S
    Exp Physiol; 2018 Apr; 103(4):439-448. PubMed ID: 29282799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research on genodermatoses using novel genome-editing tools.
    Lehmann J; Seebode C; Emmert S
    J Dtsch Dermatol Ges; 2017 Aug; 15(8):783-789. PubMed ID: 28622433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas9 Technology for the Creation of Biological Avatars Capable of Modeling and Treating Pathologies: From Discovery to the Latest Improvements.
    Nasrallah A; Sulpice E; Kobaisi F; Gidrol X; Rachidi W
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome editing in cardiovascular diseases.
    Mani I
    Prog Mol Biol Transl Sci; 2021; 181():289-308. PubMed ID: 34127197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-Specific Genome Engineering in Human Pluripotent Stem Cells.
    Merkert S; Martin U
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome Editing in Translational Medicine: An Inventory.
    Dobner J; Ramachandran H; Rossi A
    Front Biosci (Landmark Ed); 2022 Aug; 27(8):241. PubMed ID: 36042173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concerns regarding 'off-target' activity of genome editing endonucleases.
    Kadam US; Shelake RM; Chavhan RL; Suprasanna P
    Plant Physiol Biochem; 2018 Oct; 131():22-30. PubMed ID: 29653762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9-Mediated Mutagenesis of Human Pluripotent Stem Cells in Defined Xeno-Free E8 Medium.
    Soh CL; Huangfu D
    Methods Mol Biol; 2017; 1498():57-78. PubMed ID: 27709569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.